Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- MANTRA_SFA_DIH_shares_pledge_17082026_EN.rarNotification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 220 | / | 2026 | ||||||||
| Date of issue: | 2026-08-18 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| MANTRA_SFA_DIH_shares_pledge_17082026_EN.rar MANTRA_SFA_DIH_shares_pledge_17082026_EN.rar | Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD | ||||||||||
| Legal framework | Type of information | ||||
| TRANSD | Inside information | ||||
| RegulatoryData | |||||
| Collection Body | PLKNF | ||||
| Unique data record identifier | |||||
| Type of submission | New (to be used for new information) | ||||
| Voluntary information flag |  | ||||
| Date or period covered [Date or beginning of the period to which the information relates] | 2026-08-17 | ||||
| Date or period covered [Date or end of the period to which the information relates] | 2026-08-17 | ||||
| Personal data flag | | ||||
| Macierzyste państwo członkowskie, w stosownych przypadkach | PL | ||||
| DocumentReference | |||||
| Język, w którym przekazano informacje | Oryginał (ORIG) czy tłumaczenie (TRAN) | Numer referencyjny pliku danych | |||
| PL | ORIG | ||||
| SubmittingEntity | |||||
| Submitting entity LEI | or | Submitting entity name - natural person | |||
| RelatedEntity/LegalPerson | |||||
| Entity LEI | Size of the entity | Industry sector(s) | |||
| 097900BGGW0000048796 | Large undertaking | (acc. NACE): C | |||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2026-08-18 | Ognian Ivanov Donev | Executive Director | |||
